Zummo Jacqueline
- SEC CIK
- 0001798929
In the past year, 2 open-market sale filings worth $125.0K and no purchases.
Current role at each company
- TARA Protara Therapeutics, Inc.Chief R&D Officeras of Apr 9, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $125.0K
- 2 filings
- Net
- −$125.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Zummo Jacqueline as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 9, 2026 (view filing) | Apr 8 | 1 day | Zummo JacquelineChief R&D Officer | SSale | −1.13K | $5.40 | −$6.12K | −1.2%94.8K after | |
| Apr 2, 2026 (view filing) | Apr 1 | 1 day | Zummo JacquelineChief R&D Officer | SSale | −22.6K | $5.26 | −$118.9K | −19.1%96.0K after | |
| Mar 28, 2025 (view filing) | Mar 26 | 2 days | Zummo JacquelineChf Scientific Operations Off | SSale | −21.2K | $4.53 | −$96.1K | −17.7%98.9K after | 10b5-1 |